Trinity Biotech plc (TRIB) Total Return Calculator with Dividends Reinvested

Trinity Biotech plc

Popular:

The total return for Trinity Biotech plc (TRIB) stock is -90.01% over the past 12 months. So far it's down 53.36% this year. The 5-year total return is -99.51%, meaning $10,000 invested in TRIB stock 5 years ago would be worth $49 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in TRIB 1 year ago, it would be worth $1,111 today — you'd have lost $8,889.

With Dividends Reinvested$1,111-88.89%

Price Only (No DRIP)$1,111-88.89%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in TRIB

1Y$999-$9,001 (-90.0%)-90.0% CAGR

3Y$145-$9,855 (-98.6%)-75.6% CAGR

5Y$49-$9,951 (-99.5%)-65.5% CAGR

10Y$12-$9,988 (-99.9%)-48.8% CAGR

15Y$173-$9,827 (-98.3%)-23.7% CAGR

20Y$246-$9,754 (-97.5%)-16.9% CAGR

30Y$98-$9,902 (-99.0%)-14.3% CAGR

Trinity Biotech plc did not pay dividends during this period. Total return = price return.

Loading TRIB total return...

As of 2026-06-29

Performance Summary

Best Year+284.83%2003

Worst Year-83.37%2025

Max Drawdown-96.35%2025-08-14 → 2026-06-24

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-53.36%	—	-51.87%	—	$4,664
1Y	-90.01%	-90.01%	-89.35%	—	$999
3Y	-98.55%	-75.64%	-98.51%	—	$145
5Y	-99.51%	-65.54%	-99.50%	—	$49
10Y	-99.88%	-48.79%	-99.87%	—	$12
15Y	-98.27%	-23.71%	-99.85%	+1.59 pp	$173
20Y	-97.54%	-16.91%	-99.81%	+2.28 pp	$246
30Y	-99.02%	-14.27%	-99.92%	+0.91 pp	$98

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-4.07%	-4.07%	—	+0.41%	-4.5pp
2025	-83.37%	-83.37%	—	+16.64%	-100.0pp
2024	-60.00%	-60.00%	—	+24.00%	-84.0pp
2023	-59.43%	-59.43%	—	+24.81%	-84.2pp
2022	-31.15%	-31.15%	—	-19.95%	-11.2pp

TRIB underperformed the S&P 500 by 110.85pp over the past year (-90.01% vs +20.84%).

Loading summary...

TRIB Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
TRIBTrinity Biotech plc	$4M	-44.2%	-53.4%	-90.0%	—	-98.6%	-99.5%	-99.9%
OSUROraSure Technologies, Inc.	$321M	+13.2%	+82.4%	+44.7%	—	-13.0%	-54.7%	-34.3%
CHEKCheck-Cap Ltd.	$11M	—	+8.5%	+153.6%	—	-34.0%	-94.3%	-99.2%
LMATLeMaitre Vascular, Inc.	$2.2B	-3.1%	+15.7%	+9.8%	+1.1pp	+40.3%	+53.1%	+572.7%
QDELQuidelOrtho Corporation	$939M	+15.0%	-57.6%	-57.4%	—	-85.4%	-89.4%	-28.6%
CTKBCytek Biosciences, Inc.	$579M	+12.8%	-13.0%	+32.5%	—	-46.5%	-77.2%	-77.2%
ABTAbbott Laboratories	$163.4B	+8.3%	-26.1%	-32.7%	+1.8pp	-10.3%	-9.4%	+183.5%
BIOBio-Rad Laboratories, Inc.	$8.1B	+1.3%	-8.3%	+17.7%	—	-23.4%	-55.7%	+101.9%
HOLXHologic, Inc.	$17.0B	—	+1.9%	+17.2%	—	-6.2%	+16.9%	+122.8%
IDXXIDEXX Laboratories, Inc.	$43.8B	-1.0%	-18.0%	+3.5%	—	+14.0%	-10.7%	+525.8%
NEOGNeogen Corporation	$2.1B	+4.8%	+31.1%	+86.2%	—	-57.1%	-80.0%	-53.1%

Compare:TRIB vs OSUR TRIB vs CHEK TRIB vs LMAT TRIB vs OSUR vs CHEK

About TRIB Dividend Returns

Trinity Biotech plc (TRIB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of TRIB over the past year?

Trinity Biotech plc (TRIB) delivered a return of -90.01% over the past year. Since TRIB does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in TRIB be worth today?

A $10,000 investment in Trinity Biotech plc one year ago would be worth $999 today, representing a loss of $9,001.

Q3Does TRIB pay dividends?

Trinity Biotech plc (TRIB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TRIB, the total return equals the price-only return.

Q4Did TRIB beat the S&P 500?

No, Trinity Biotech plc (TRIB) underperformed the S&P 500 by 110.85 percentage points over the past year. TRIB delivered a total return of -90.01%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed TRIB by 110.85pp during this period.

Q5What is TRIB's worst drawdown?

Trinity Biotech plc (TRIB) experienced a maximum drawdown of -96.35% over the past year, declining from its peak on 2025-08-14 to its trough on 2026-06-24. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is TRIB's long-term total return over 10, 20, or 30 years?

Here are Trinity Biotech plc (TRIB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.9% (-48.8% CAGR) — $10,000 would have grown to $12. Over 20 years: -97.5% total return (-16.9% CAGR) — $10,000 → $246. Over 30 years: -99.0% total return (-14.3% CAGR) — $10,000 → $98. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was TRIB's best and worst year?

Trinity Biotech plc's best calendar year was 2003 with a total return of 284.8%. Its worst year was 2025 with a total return of -83.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 368.2 percentage points.

How much would $100/month in TRIB be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →